4.3 Article

Nucleic Acid Quality Assessment is Critical to the Success of the Oncomine Dx Target Test for Lung Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Real-world data on NGS using the Oncomine DxTT for detecting genetic alterations in non-small-cell lung cancer: WJOG13019L

Shinya Sakata et al.

Summary: This study evaluated real-world clinical data of NSCLC patients using Oncomine DxTT as a companion diagnostic system and found that surgical resection was associated with a higher success rate in genetic alteration testing. The study results indicate that the success rate of genetic alteration testing was not satisfactory immediately after Oncomine DxTT induction, but optimizing specimen quantity and quality may improve driver gene testing in clinical settings.

CANCER SCIENCE (2022)

Article Oncology

Molecular analysis of ascitic fluid cytology reflects genetic changes of malignancies of the ovary equivalent to surgically resected specimens

Takahiro Nozaki et al.

Summary: The study showed that genomic analysis of ascitic fluid can effectively identify genetic changes associated with epithelial ovarian cancer, providing important information for personalized precision medicine without the need for surgical intervention or biopsy. The concordance rate of molecular profiles between ascitic fluid samples and surgically resected tissues was significantly higher for oncogenic mutations compared to nononcogenic mutations.

CANCER CYTOPATHOLOGY (2022)

Article Pathology

Detection of actionable mutations in cytological specimens obtained by endoscopic ultrasound-guided fine needle aspiration with rapid onsite evaluation in pancreatic cancer

Hiroshi Ohyama et al.

Summary: This study demonstrates the usefulness of genomic analysis of archived cytological specimens (ACSs) in identifying oncogenic mutations in pancreatic cancer, with comparable sensitivity and detection rate to formalin-fixed paraffin-embedded (FFPE) tissues.

ANNALS OF DIAGNOSTIC PATHOLOGY (2022)

Article Oncology

Comparison of the analytical performance between the Oncomine Dx Target Test and a conventional single gene test for epidermal growth factor receptor mutation in non-small cell lung cancer

Tadashi Sakaguchi et al.

Summary: This study compared the performance of the Oncomine Dx Target Test with a PNA-LNA PCR clamp test in detecting EGFR mutations in non-small cell lung cancer patients. The success rate of the Oncomine Dx Target Test was significantly lower than the PNA-LNA PCR clamp test, and four exon 19 deletions were not detected by the Oncomine Dx Target Test among successfully analyzed samples. The analytical performance of the Oncomine Dx Target Test may not be comparable with conventional single gene tests, highlighting the need for improvements in sampling procedures and sample quality assessment methods.

THORACIC CANCER (2021)

Article Pathology

The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicine

Yutaka Hatanaka et al.

Summary: Clinical cancer genomic testing can help select appropriate therapy and provide diagnostic and prognostic information. The article focuses on standardizing the handling of pathological specimens for genomic medicine based on guidelines from the Japanese Society of Pathology. These guidelines are supported by empirical data and recommend using FFPE samples within 3 years of preparation with a tumor content of >= 30% (minimum 20%).

PATHOLOGY INTERNATIONAL (2021)

Article Medicine, General & Internal

Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation Sequencing

Shuji Murakami et al.

Summary: For patients with advanced non-small-cell lung cancer, having a tissue surface area of >= 1 mm^2 is sufficient for successful testing with NGS, regardless of the device used. The success rate of DNA and RNA sequencing was high overall, with large EBUS-GS demonstrating the highest success rates.

DIAGNOSTICS (2021)

Article Oncology

Actionable driver DNA variants and fusion genes can be detected in archived cytological specimens with the Oncomine Dx Target Test Multi-CDx system in lung cancer

Kenji Amemiya et al.

Summary: This study examined whether oncogenic variants could be accurately detected in cytological specimens compared to paired formalin-fixed, paraffin-embedded tumor tissues using the Oncomine Dx Target Test Multi-CDx system. Results demonstrated that ACSs can be a feasible alternative for identifying actionable mutations and fusion genes.

CANCER CYTOPATHOLOGY (2021)

Letter Respiratory System

A method to improve genetic analysis of lung cancer samples

Tadashi Sakaguchi et al.

RESPIROLOGY (2021)

Article Oncology

Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients

Yuki Takeyasu et al.

Summary: Tissue size and tumor cell content were significantly associated with the success rate of Oncomine (TM) Dx Target Test companion diagnostics.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

Tissue surface area and tumor cell count affect the success rate of the Oncomine Dx Target Test in the analysis of biopsy tissue samples

Daiji Nemoto et al.

Summary: The study identified that a tissue surface area > 1.04 mm(2) and tumor cell count >375 cells have a positive effect on the analysis success rate of ODxTT. This information can help determine which tests should be performed, ODxTT or multiple single-gene testing, especially when dealing with small biopsy samples.

THORACIC CANCER (2021)

Article Medicine, General & Internal

Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations

Paul K. Paik et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer

Yi-Long Wu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer

Juergen Wolf et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer

J. -C. Soria et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, General & Internal

Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer

Solange Peters et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

David M. Hyman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer

Alice T. Shaw et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Respiratory System

Lung Cancer: Epidemiology, Etiology, and Prevention

Charles S. Dela Cruz et al.

CLINICS IN CHEST MEDICINE (2011)

Review Medicine, General & Internal

Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship

Julian R. Molina et al.

MAYO CLINIC PROCEEDINGS (2008)